These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34623063)

  • 1. Fibrin clot properties in coronary artery disease: new determinants and prognostic markers.
    Larsen JB; Hvas AM
    Pol Arch Intern Med; 2021 Nov; 131(11):. PubMed ID: 34623063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
    Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
    Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen and a Triad of Thrombosis, Inflammation, and the Renin-Angiotensin System in Premature Coronary Artery Disease in Women: A New Insight into Sex-Related Differences in the Pathogenesis of the Disease.
    Kryczka KE; Kruk M; Demkow M; Lubiszewska B
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance between Fibrin Clot Formation and Fibrinolysis Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
    Neergaard-Petersen S; Larsen SB; Grove EL; Kristensen SD; Ajjan RA; Hvas AM
    Thromb Haemost; 2020 Jan; 120(1):75-82. PubMed ID: 31733633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and subacute effects of strenuous exercise on platelet aggregation, coagulation and fibrinolysis in patients with stable coronary artery disease.
    Kristiansen J; Grove EL; Sjúrðarson T; Mohr M; Kristensen SD; Hvas AM
    Thromb Res; 2024 Apr; 236():220-227. PubMed ID: 38484628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
    Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
    Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis.
    Collet JP; Allali Y; Lesty C; Tanguy ML; Silvain J; Ankri A; Blanchet B; Dumaine R; Gianetti J; Payot L; Weisel JW; Montalescot G
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2567-73. PubMed ID: 16917107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of depression to various markers of coagulation and fibrinolysis in patients with and without coronary artery disease.
    Schroeder V; Borner U; Gutknecht S; Schmid JP; Saner H; Kohler HP
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):782-7. PubMed ID: 18043299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood clot properties, thrombin generation, and platelet activation in patients with dysglycemia and established atherosclerotic cardiovascular disease: The CASCARA study.
    Siniarski A; Gołębiowska-Wiatrak R; Malinowski KP; Gajos G
    Kardiol Pol; 2024; 82(6):617-624. PubMed ID: 38606741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gastric bypass followed by a randomized study of physical training on markers of coagulation activation, fibrin clot properties, and fibrinolysis.
    Stolberg CR; Mundbjerg LH; Funch-Jensen P; Gram B; Juhl CB; Bladbjerg EM
    Surg Obes Relat Dis; 2018 Jul; 14(7):918-926. PubMed ID: 29706497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
    Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease.
    Bochenek M; Zalewski J; Sadowski J; Undas A
    J Thromb Thrombolysis; 2013 Feb; 35(2):264-70. PubMed ID: 23086579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin clot formation and fibrinolysis in patients with a history of coronary stent thrombosis.
    Godschalk TC; Konings J; Govers-Riemslag JW; Ten Berg JM; Hackeng CM; Ten Cate H
    Thromb Res; 2016 Jul; 143():58-62. PubMed ID: 27191854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
    Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
    Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis in Acute and Chronic Cardiovascular Disease.
    Kietsiriroje N; Ariëns RAS; Ajjan RA
    Semin Thromb Hemost; 2021 Jul; 47(5):490-505. PubMed ID: 33878782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ABO Locus is Associated with Increased Fibrin Network Formation in Patients with Stable Coronary Artery Disease.
    Winther-Larsen A; Christiansen MK; Larsen SB; Nyegaard M; Neergaard-Petersen S; Ajjan RA; Würtz M; Grove EL; Jensen HK; Kristensen SD; Hvas AM
    Thromb Haemost; 2020 Sep; 120(9):1248-1256. PubMed ID: 32604426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombosis and Aging: Fibrin Clot Properties and Oxidative Stress.
    Konieczyńska M; Natorska J; Undas A
    Antioxid Redox Signal; 2024 Aug; 41(4-6):233-254. PubMed ID: 38062775
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of hypofibrinolysis in stable coronary artery disease using the overall haemostatic potential assay.
    Reddel CJ; Curnow JL; Voitl J; Rosenov A; Pennings GJ; Morel-Kopp MC; Brieger DB
    Thromb Res; 2013 May; 131(5):457-62. PubMed ID: 23582780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous fibrinolysis-Relevance to clinical thrombosis risk assessment.
    Kanji R; Kubica J; Navarese EP; Gorog DA
    Eur J Clin Invest; 2021 Apr; 51(4):e13471. PubMed ID: 33296082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis.
    Muszbek L; Bagoly Z; Bereczky Z; Katona E
    Cardiovasc Hematol Agents Med Chem; 2008 Jul; 6(3):190-205. PubMed ID: 18673233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.